Micro Organisms in Recent Drug Discovery
Environmental microbes are a leading source of drug discovery, and several microbial products ( anti-tumour products, antibiotics, immunosuppressants and others) are used frequently for human therapies. Most of these products were accessed from cultivable (<1%) environmental microbes, means that the large number of microbes were not targeted for drug discovery. With the onset of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. Multidisciplinary way of linking different technologies can assist and reform drug discovery from uncultivable microbes and inspect the current cramp of technologies and scenario to swamped such constraints that might further expand the promise of drugs from environmental microbes
- Novel species discovery
- Micos from different areas (patients, geographical locations)
- Genetically modified organisms
Related Conference of Micro Organisms in Recent Drug Discovery
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Micro Organisms in Recent Drug Discovery Conference Speakers
Recommended Sessions
- Antibiotic Prophylaxis
- Antibiotic Resistance: Opportunities and Challenges
- Antibiotic-resistant Bacterial infections
- Antibiotics
- Antibiotics for Various Diseases and Infections
- Antibiotics: In Pregnancy and Lactation
- Antimicrobial Peptides
- Antimicrobial Therapy
- Clinical Trials of Antibiotics
- Current research in antibiotic resistance
- Developing Alternatives to Antibiotics
- Drug Discovery and Novel Delivery Technologies
- Immunology & Vaccines
- Infectious Diseases
- Mechanism and Evolution of Antibiotic Resistance
- Micro Organisms in Recent Drug Discovery
- Microorganisms Producing Antibiotics
- Modern Antibiotics for Various Diseases and Infections
- New antibiotics and non-antibiotic approaches
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs
- Pharmacology & Toxicology
- Prevention and Control of Antibiotic Resistance
- The Next Generation Approach of Antibiotics
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)